0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Colorectal Cancer Market Research Report 2023
Published Date: April 2023
|
Report Code: QYRE-Auto-14X2396
Home | Market Reports | Health| Health Conditions| Cancer
Global Colorectal Cancer Market Insights and Forecast to 2028
BUY CHAPTERS

Global Colorectal Cancer Market Research Report 2023

Code: QYRE-Auto-14X2396
Report
April 2023
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Colorectal Cancer Market

Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine).
The global Colorectal Cancer market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major symptoms associated with colorectal cancer include diarrhea, constipation, blood in feces, pain in abdomen, loss of appetite, loss of weight, nausea, vomiting, fatigue, lump in back passage, and iron deficiency in aged person.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer.
The Colorectal Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Colorectal Cancer market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Colorectal Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Scope of Global Colorectal Cancer Market Report

Report MetricDetails
Report NameGlobal Colorectal Cancer Market
Base Year2022
Forecasted years2023-2029
By Company
  • Roche
  • Debiopharm
  • Merck Kgaa
  • Vaccinogen
  • Aeterna Zentaris
  • Keryx
  • Spectrum Pharmaceuticals
  • Mologen
  • Amgen
  • Bayer Healthcare
Segment by Type
  • Chemotherapy
  • Targeted therapy
  • Immunotherapy
Segment by Application
  • Early Colorectal Cancer
  • Midterm Colorectal Cancer
  • Late Colorectal Cancer
By Region
  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Colorectal Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Chemotherapy
1.2.3 Targeted therapy
1.2.4 Immunotherapy
1.3 Market by Application
1.3.1 Global Colorectal Cancer Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Early Colorectal Cancer
1.3.3 Midterm Colorectal Cancer
1.3.4 Late Colorectal Cancer
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Colorectal Cancer Market Perspective (2018-2029)
2.2 Colorectal Cancer Growth Trends by Region
2.2.1 Global Colorectal Cancer Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Colorectal Cancer Historic Market Size by Region (2018-2023)
2.2.3 Colorectal Cancer Forecasted Market Size by Region (2024-2029)
2.3 Colorectal Cancer Market Dynamics
2.3.1 Colorectal Cancer Industry Trends
2.3.2 Colorectal Cancer Market Drivers
2.3.3 Colorectal Cancer Market Challenges
2.3.4 Colorectal Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Players by Revenue
3.1.1 Global Top Colorectal Cancer Players by Revenue (2018-2023)
3.1.2 Global Colorectal Cancer Revenue Market Share by Players (2018-2023)
3.2 Global Colorectal Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Colorectal Cancer Revenue
3.4 Global Colorectal Cancer Market Concentration Ratio
3.4.1 Global Colorectal Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Revenue in 2022
3.5 Colorectal Cancer Key Players Head office and Area Served
3.6 Key Players Colorectal Cancer Product Solution and Service
3.7 Date of Enter into Colorectal Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Colorectal Cancer Breakdown Data by Type
4.1 Global Colorectal Cancer Historic Market Size by Type (2018-2023)
4.2 Global Colorectal Cancer Forecasted Market Size by Type (2024-2029)
5 Colorectal Cancer Breakdown Data by Application
5.1 Global Colorectal Cancer Historic Market Size by Application (2018-2023)
5.2 Global Colorectal Cancer Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Colorectal Cancer Market Size (2018-2029)
6.2 North America Colorectal Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Colorectal Cancer Market Size by Country (2018-2023)
6.4 North America Colorectal Cancer Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Colorectal Cancer Market Size (2018-2029)
7.2 Europe Colorectal Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Colorectal Cancer Market Size by Country (2018-2023)
7.4 Europe Colorectal Cancer Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Market Size (2018-2029)
8.2 Asia-Pacific Colorectal Cancer Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Colorectal Cancer Market Size by Region (2018-2023)
8.4 Asia-Pacific Colorectal Cancer Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Colorectal Cancer Market Size (2018-2029)
9.2 Latin America Colorectal Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Colorectal Cancer Market Size by Country (2018-2023)
9.4 Latin America Colorectal Cancer Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Market Size (2018-2029)
10.2 Middle East & Africa Colorectal Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Colorectal Cancer Market Size by Country (2018-2023)
10.4 Middle East & Africa Colorectal Cancer Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Colorectal Cancer Introduction
11.1.4 Roche Revenue in Colorectal Cancer Business (2018-2023)
11.1.5 Roche Recent Development
11.2 Debiopharm
11.2.1 Debiopharm Company Detail
11.2.2 Debiopharm Business Overview
11.2.3 Debiopharm Colorectal Cancer Introduction
11.2.4 Debiopharm Revenue in Colorectal Cancer Business (2018-2023)
11.2.5 Debiopharm Recent Development
11.3 Merck Kgaa
11.3.1 Merck Kgaa Company Detail
11.3.2 Merck Kgaa Business Overview
11.3.3 Merck Kgaa Colorectal Cancer Introduction
11.3.4 Merck Kgaa Revenue in Colorectal Cancer Business (2018-2023)
11.3.5 Merck Kgaa Recent Development
11.4 Vaccinogen
11.4.1 Vaccinogen Company Detail
11.4.2 Vaccinogen Business Overview
11.4.3 Vaccinogen Colorectal Cancer Introduction
11.4.4 Vaccinogen Revenue in Colorectal Cancer Business (2018-2023)
11.4.5 Vaccinogen Recent Development
11.5 Aeterna Zentaris
11.5.1 Aeterna Zentaris Company Detail
11.5.2 Aeterna Zentaris Business Overview
11.5.3 Aeterna Zentaris Colorectal Cancer Introduction
11.5.4 Aeterna Zentaris Revenue in Colorectal Cancer Business (2018-2023)
11.5.5 Aeterna Zentaris Recent Development
11.6 Keryx
11.6.1 Keryx Company Detail
11.6.2 Keryx Business Overview
11.6.3 Keryx Colorectal Cancer Introduction
11.6.4 Keryx Revenue in Colorectal Cancer Business (2018-2023)
11.6.5 Keryx Recent Development
11.7 Spectrum Pharmaceuticals
11.7.1 Spectrum Pharmaceuticals Company Detail
11.7.2 Spectrum Pharmaceuticals Business Overview
11.7.3 Spectrum Pharmaceuticals Colorectal Cancer Introduction
11.7.4 Spectrum Pharmaceuticals Revenue in Colorectal Cancer Business (2018-2023)
11.7.5 Spectrum Pharmaceuticals Recent Development
11.8 Mologen
11.8.1 Mologen Company Detail
11.8.2 Mologen Business Overview
11.8.3 Mologen Colorectal Cancer Introduction
11.8.4 Mologen Revenue in Colorectal Cancer Business (2018-2023)
11.8.5 Mologen Recent Development
11.9 Amgen
11.9.1 Amgen Company Detail
11.9.2 Amgen Business Overview
11.9.3 Amgen Colorectal Cancer Introduction
11.9.4 Amgen Revenue in Colorectal Cancer Business (2018-2023)
11.9.5 Amgen Recent Development
11.10 Bayer Healthcare
11.10.1 Bayer Healthcare Company Detail
11.10.2 Bayer Healthcare Business Overview
11.10.3 Bayer Healthcare Colorectal Cancer Introduction
11.10.4 Bayer Healthcare Revenue in Colorectal Cancer Business (2018-2023)
11.10.5 Bayer Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Colorectal Cancer Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Chemotherapy
    Table 3. Key Players of Targeted therapy
    Table 4. Key Players of Immunotherapy
    Table 5. Global Colorectal Cancer Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Colorectal Cancer Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global Colorectal Cancer Market Size by Region (2018-2023) & (US$ Million)
    Table 8. Global Colorectal Cancer Market Share by Region (2018-2023)
    Table 9. Global Colorectal Cancer Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 10. Global Colorectal Cancer Market Share by Region (2024-2029)
    Table 11. Colorectal Cancer Market Trends
    Table 12. Colorectal Cancer Market Drivers
    Table 13. Colorectal Cancer Market Challenges
    Table 14. Colorectal Cancer Market Restraints
    Table 15. Global Colorectal Cancer Revenue by Players (2018-2023) & (US$ Million)
    Table 16. Global Colorectal Cancer Market Share by Players (2018-2023)
    Table 17. Global Top Colorectal Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer as of 2022)
    Table 18. Ranking of Global Top Colorectal Cancer Companies by Revenue (US$ Million) in 2022
    Table 19. Global 5 Largest Players Market Share by Colorectal Cancer Revenue (CR5 and HHI) & (2018-2023)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Colorectal Cancer Product Solution and Service
    Table 22. Date of Enter into Colorectal Cancer Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Colorectal Cancer Market Size by Type (2018-2023) & (US$ Million)
    Table 25. Global Colorectal Cancer Revenue Market Share by Type (2018-2023)
    Table 26. Global Colorectal Cancer Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Global Colorectal Cancer Revenue Market Share by Type (2024-2029)
    Table 28. Global Colorectal Cancer Market Size by Application (2018-2023) & (US$ Million)
    Table 29. Global Colorectal Cancer Revenue Market Share by Application (2018-2023)
    Table 30. Global Colorectal Cancer Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 31. Global Colorectal Cancer Revenue Market Share by Application (2024-2029)
    Table 32. North America Colorectal Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. North America Colorectal Cancer Market Size by Country (2018-2023) & (US$ Million)
    Table 34. North America Colorectal Cancer Market Size by Country (2024-2029) & (US$ Million)
    Table 35. Europe Colorectal Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Europe Colorectal Cancer Market Size by Country (2018-2023) & (US$ Million)
    Table 37. Europe Colorectal Cancer Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Asia-Pacific Colorectal Cancer Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Asia-Pacific Colorectal Cancer Market Size by Region (2018-2023) & (US$ Million)
    Table 40. Asia-Pacific Colorectal Cancer Market Size by Region (2024-2029) & (US$ Million)
    Table 41. Latin America Colorectal Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Latin America Colorectal Cancer Market Size by Country (2018-2023) & (US$ Million)
    Table 43. Latin America Colorectal Cancer Market Size by Country (2024-2029) & (US$ Million)
    Table 44. Middle East & Africa Colorectal Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Middle East & Africa Colorectal Cancer Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Middle East & Africa Colorectal Cancer Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Roche Company Detail
    Table 48. Roche Business Overview
    Table 49. Roche Colorectal Cancer Product
    Table 50. Roche Revenue in Colorectal Cancer Business (2018-2023) & (US$ Million)
    Table 51. Roche Recent Development
    Table 52. Debiopharm Company Detail
    Table 53. Debiopharm Business Overview
    Table 54. Debiopharm Colorectal Cancer Product
    Table 55. Debiopharm Revenue in Colorectal Cancer Business (2018-2023) & (US$ Million)
    Table 56. Debiopharm Recent Development
    Table 57. Merck Kgaa Company Detail
    Table 58. Merck Kgaa Business Overview
    Table 59. Merck Kgaa Colorectal Cancer Product
    Table 60. Merck Kgaa Revenue in Colorectal Cancer Business (2018-2023) & (US$ Million)
    Table 61. Merck Kgaa Recent Development
    Table 62. Vaccinogen Company Detail
    Table 63. Vaccinogen Business Overview
    Table 64. Vaccinogen Colorectal Cancer Product
    Table 65. Vaccinogen Revenue in Colorectal Cancer Business (2018-2023) & (US$ Million)
    Table 66. Vaccinogen Recent Development
    Table 67. Aeterna Zentaris Company Detail
    Table 68. Aeterna Zentaris Business Overview
    Table 69. Aeterna Zentaris Colorectal Cancer Product
    Table 70. Aeterna Zentaris Revenue in Colorectal Cancer Business (2018-2023) & (US$ Million)
    Table 71. Aeterna Zentaris Recent Development
    Table 72. Keryx Company Detail
    Table 73. Keryx Business Overview
    Table 74. Keryx Colorectal Cancer Product
    Table 75. Keryx Revenue in Colorectal Cancer Business (2018-2023) & (US$ Million)
    Table 76. Keryx Recent Development
    Table 77. Spectrum Pharmaceuticals Company Detail
    Table 78. Spectrum Pharmaceuticals Business Overview
    Table 79. Spectrum Pharmaceuticals Colorectal Cancer Product
    Table 80. Spectrum Pharmaceuticals Revenue in Colorectal Cancer Business (2018-2023) & (US$ Million)
    Table 81. Spectrum Pharmaceuticals Recent Development
    Table 82. Mologen Company Detail
    Table 83. Mologen Business Overview
    Table 84. Mologen Colorectal Cancer Product
    Table 85. Mologen Revenue in Colorectal Cancer Business (2018-2023) & (US$ Million)
    Table 86. Mologen Recent Development
    Table 87. Amgen Company Detail
    Table 88. Amgen Business Overview
    Table 89. Amgen Colorectal Cancer Product
    Table 90. Amgen Revenue in Colorectal Cancer Business (2018-2023) & (US$ Million)
    Table 91. Amgen Recent Development
    Table 92. Bayer Healthcare Company Detail
    Table 93. Bayer Healthcare Business Overview
    Table 94. Bayer Healthcare Colorectal Cancer Product
    Table 95. Bayer Healthcare Revenue in Colorectal Cancer Business (2018-2023) & (US$ Million)
    Table 96. Bayer Healthcare Recent Development
    Table 97. Research Programs/Design for This Report
    Table 98. Key Data Information from Secondary Sources
    Table 99. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Colorectal Cancer Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Colorectal Cancer Market Share by Type: 2022 VS 2029
    Figure 3. Chemotherapy Features
    Figure 4. Targeted therapy Features
    Figure 5. Immunotherapy Features
    Figure 6. Global Colorectal Cancer Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global Colorectal Cancer Market Share by Application: 2022 VS 2029
    Figure 8. Early Colorectal Cancer Case Studies
    Figure 9. Midterm Colorectal Cancer Case Studies
    Figure 10. Late Colorectal Cancer Case Studies
    Figure 11. Colorectal Cancer Report Years Considered
    Figure 12. Global Colorectal Cancer Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 13. Global Colorectal Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Colorectal Cancer Market Share by Region: 2022 VS 2029
    Figure 15. Global Colorectal Cancer Market Share by Players in 2022
    Figure 16. Global Top Colorectal Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer as of 2022)
    Figure 17. The Top 10 and 5 Players Market Share by Colorectal Cancer Revenue in 2022
    Figure 18. North America Colorectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 19. North America Colorectal Cancer Market Share by Country (2018-2029)
    Figure 20. United States Colorectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Canada Colorectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Colorectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Europe Colorectal Cancer Market Share by Country (2018-2029)
    Figure 24. Germany Colorectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. France Colorectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. U.K. Colorectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Italy Colorectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Russia Colorectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Nordic Countries Colorectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Asia-Pacific Colorectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Asia-Pacific Colorectal Cancer Market Share by Region (2018-2029)
    Figure 32. China Colorectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Japan Colorectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. South Korea Colorectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Southeast Asia Colorectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. India Colorectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Australia Colorectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Latin America Colorectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Latin America Colorectal Cancer Market Share by Country (2018-2029)
    Figure 40. Mexico Colorectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Brazil Colorectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Middle East & Africa Colorectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Middle East & Africa Colorectal Cancer Market Share by Country (2018-2029)
    Figure 44. Turkey Colorectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Saudi Arabia Colorectal Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Roche Revenue Growth Rate in Colorectal Cancer Business (2018-2023)
    Figure 47. Debiopharm Revenue Growth Rate in Colorectal Cancer Business (2018-2023)
    Figure 48. Merck Kgaa Revenue Growth Rate in Colorectal Cancer Business (2018-2023)
    Figure 49. Vaccinogen Revenue Growth Rate in Colorectal Cancer Business (2018-2023)
    Figure 50. Aeterna Zentaris Revenue Growth Rate in Colorectal Cancer Business (2018-2023)
    Figure 51. Keryx Revenue Growth Rate in Colorectal Cancer Business (2018-2023)
    Figure 52. Spectrum Pharmaceuticals Revenue Growth Rate in Colorectal Cancer Business (2018-2023)
    Figure 53. Mologen Revenue Growth Rate in Colorectal Cancer Business (2018-2023)
    Figure 54. Amgen Revenue Growth Rate in Colorectal Cancer Business (2018-2023)
    Figure 55. Bayer Healthcare Revenue Growth Rate in Colorectal Cancer Business (2018-2023)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Cervical Cancer Molecular Diagnostics Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-34X5672
Tue Feb 20 00:00:00 UTC 2024

Add to Cart

Global Squamous Cell Carcinoma Antigen Quantitative Determination Kit Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-9X8498
Tue Feb 20 00:00:00 UTC 2024

Add to Cart

Global Breast Cancer Molecular Diagnostics Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-23F5603
Tue Feb 20 00:00:00 UTC 2024

Add to Cart

Global Pancreatic Cancer Molecular Diagnostics Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-32K5763
Tue Feb 20 00:00:00 UTC 2024

Add to Cart